BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 536 filers reported holding BIO-TECHNE CORP in Q1 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,417 | -67.2% | 2,488 | -44.0% | 0.01% | -27.3% |
| Q2 2023 | $516,925 | +1122.9% | 4,444 | +1487.1% | 0.01% | +450.0% |
| Q1 2023 | $42,271 | +52738.8% | 280 | -46.3% | 0.00% | 0.0% |
| Q4 2022 | $80 | -99.8% | 521 | +202.9% | 0.00% | +100.0% |
| Q3 2022 | $39,000 | 0.0% | 172 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $39,000 | -48.0% | 176 | -53.4% | 0.00% | 0.0% |
| Q1 2022 | $75,000 | -9.6% | 378 | +140.8% | 0.00% | -50.0% |
| Q4 2021 | $83,000 | +31.7% | 157 | +20.8% | 0.00% | +100.0% |
| Q3 2021 | $63,000 | +1.6% | 130 | -11.6% | 0.00% | 0.0% |
| Q2 2021 | $62,000 | +19.2% | 147 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $52,000 | +333.3% | 145 | +202.1% | 0.00% | – |
| Q4 2020 | $12,000 | +140.0% | 48 | +152.6% | 0.00% | – |
| Q3 2020 | $5,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 19 | -9.5% | 0.00% | – |
| Q1 2020 | $4,000 | -73.3% | 21 | -70.8% | 0.00% | -100.0% |
| Q4 2019 | $15,000 | +25.0% | 72 | +20.0% | 0.00% | 0.0% |
| Q3 2019 | $12,000 | +300.0% | 60 | +200.0% | 0.00% | – |
| Q4 2018 | $3,000 | -78.6% | 20 | -70.1% | 0.00% | -100.0% |
| Q3 2018 | $14,000 | +55.6% | 67 | +4.7% | 0.00% | – |
| Q2 2018 | $9,000 | 0.0% | 64 | -3.0% | 0.00% | – |
| Q1 2018 | $9,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q4 2017 | $9,000 | +12.5% | 66 | 0.0% | 0.00% | – |
| Q3 2017 | $8,000 | 0.0% | 66 | 0.0% | 0.00% | – |
| Q2 2017 | $8,000 | +14.3% | 66 | 0.0% | 0.00% | – |
| Q1 2017 | $7,000 | +40.0% | 66 | +29.4% | 0.00% | – |
| Q4 2016 | $5,000 | +400.0% | 51 | +325.0% | 0.00% | – |
| Q3 2016 | $1,000 | -66.7% | 12 | -50.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 24 | -52.9% | 0.00% | – |
| Q4 2015 | $5,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadcrest Asset Management, LLC | 275,000 | $18,719,250 | 20.14% |
| Montanaro Asset Management Ltd | 408,800 | $27,827,016 | 4.90% |
| Sandhill Capital Partners LLC | 613,061 | $41,731,091 | 3.90% |
| Pembroke Management, LTD | 365,611 | $24,887,141 | 3.40% |
| DF DENT & CO INC | 3,349,047 | $227,969,648 | 3.34% |
| Brown Capital Management | 3,158,004 | $214,965,332 | 3.30% |
| Ownership Capital B.V. | 1,786,273 | $121,591,603 | 3.05% |
| STONE RUN CAPITAL, LLC | 86,335 | $5,876,823 | 2.88% |
| Jackson Square Partners, LLC | 1,260,547 | $85,805,434 | 2.87% |
| Summit Creek Advisors LLC | 284,681 | $19,378,236 | 2.64% |